In the current clinical practice, although only BRCA1 and BRCA2 are routinely evaluated in terms of large genomic rearrangements (LGRs), it has been observed that an important proportion of PALB2 PVs in BC subjects are LGRs [85]. The gene discussed is BRCA2; the disease is breast cancer.